Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 47.23 Billion | USD 71.53 Billion | 4.72% | 2023 |
According to Zion Market Research, the global Home infusion therapy Market was worth USD 47.23 Billion in 2023. The market is forecast to reach USD 71.53 Billion by 2032, growing at a compound annual growth rate (CAGR) of 4.72% during the forecast period 2024-2032. The report offers a comprehensive analysis of the market, highlighting the factors that will determine growth, potential challenges, and opportunities that could emerge in the Home infusion therapy Market industry over the next decade.
Infusion therapy involves the administration of drug intravenously. It is prescribed when a patient’s condition is much severe and cannot be treated effectively by oral medications. Technological advances have enabled safe and effective administration of infusion therapies at home. Infusion therapy is required in several health conditions which include infections that are not responsive to oral antibiotics, cancer-related pain, dehydration, gastrointestinal disorders and much more. For individuals requiring long-term therapy, inpatient care is needed Home infusion has been proven to be a safe and effective alternative.
Global home infusion therapy market is primarily driven by growing aging population and prevalence of chronic diseases such as cancer, obesity, diabetes, asthma, and other life-threatening conditions. In addition to this, the adoption of home infusion therapy products as well as services in underdeveloped and developed regions has augmented due to cost-effective treatments in the past few years, thereby fueling growth of the market
Nonetheless, rising preference for homecare facilities is likely to disclose the new avenues for home infusion therapy market in the near future.
Report Attributes | Report Details |
---|---|
Report Name | Home infusion therapy Market |
Market Size in 2023 | USD 47.23 Billion |
Market Forecast in 2032 | USD 71.53 Billion |
Growth Rate | CAGR of 4.72% |
Number of Pages | 145 |
Key Companies Covered | Baxter, B. Braun Melsungen AG, Care Fusion Corporation, ICU Medical, Inc., Fresenius Kabi AG, JMS Co. Ltd., Terumo Corporation, Smiths Medical and Caesarea Medical Electronics among others. |
Segments Covered | By Products, By Application Types and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Segment Analysis Preview
Based on Product type, the market can be segmented into the infusion pump, intravenous sets, IV cannulas and needleless connectors. Infusion pump was the major segment and it accounted the major share of total revenue generated in 2020. Needleless connectors are fastest growing segments in this market. On the basis of application type, the market is divided into anti-infectives, endocrinology, enteral nutrition, hydration therapy, chemotherapy, parenteral infusion, immunoglobulin infusion and others. Anti-infectives was the major segment and it accounted for over maximum share of total revenue generated in 2023. Enteral nutrition, parenteral infusion, and chemotherapy were the fastest growing segments in this market.
Regional Analysis Preview
The global home infusion therapy market by North America and it held a maximum share of total revenue generated in 2023. This growth can be attributed to the presence of key players and good health awareness among people. The growth is also due to a large number of chronic diseases and growing geriatric population in this region. There is a significant increase in IV based therapy drugs to treat chronic and rare diseases (including blood factors, corticosteroids, growth hormones, immunoglobulin, monoclonal therapies and others) are being infused in home settings. There is a rise in adoption of home infusion therapy in the administration of anti-infectives such as antibiotics, antiviral, antifungal drugs, chemotherapy drugs, parenteral nutrition, hydration products and pain management.
Europe is another leading regional market followed by North America on account of advanced medical facilities and growing number of specialty-pharmacy and home-infusion centers in European countries. The region has a lot to offer, as the population is more health conscious and faster adoption rate of home infusion therapy due to rise in per capita income. Asia Pacific was a fastest growing market on account of rising geriatric population, rising disposable income and increasing consumer spending towards healthcare. The region is fastest developing owing to raising awareness among people regarding the use of infusion drug therapies in hospitals and healthcare facilities. Latin America was emerging market with rising healthcare infrastructure. Brazil and rest of Latin America are anticipated to fuel the market growth in coming years.
Some of the major players of the global home infusion therapy market include
By Products
By Application Types
By Region
FrequentlyAsked Questions
The global Home infusion therapy Market was valued at USD 47.23 Billion in 2023.
The global Home infusion therapy Market is expected to reach USD 71.53 Billion by 2032, growing at a CAGR of 4.72% between 2024 to 2032.
Some of the key factors driving the global Home infusion therapy Market growth are growing aging population and prevalence of chronic diseases such as cancer, obesity, diabetes, asthma, and other life-threatening conditions.
The global home infusion therapy market by North America and it held a maximum share of total revenue generated in 2020. This growth can be attributed to the presence of key players and good health awareness among people. The growth is also due to a large number of chronic diseases and growing geriatric population in this region.
Some of the major players of global Home infusion therapy market Baxter, B. Braun Melsungen AG, Care Fusion Corporation, ICU Medical, Inc., Fresenius Kabi AG, JMS Co. Ltd., Terumo Corporation, Smiths Medical and Caesarea Medical Electronics among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed